NCT01890486 The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
| NCT ID | NCT01890486 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Wake Forest University Health Sciences |
| Condition | Acute Myelogenous Leukemia |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2001-05-21 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2001-05-21 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To provide the IRB approved mechanism for the prospective collection and analysis on participants who are undergoing either an autologous or allogeneic hematopoietic stem cell transplant for a disease in which a research question is not being addressed.
Eligibility Criteria
Inclusion Criteria: Planned standard of care dose intensive therapy and either an allogeneic or autologous bone marrow transplant Exclusion Criteria: Participation in any other treatment research protocol
Contact & Investigator
Dianna Howard, MD
✉ dhoward@wakehealth.eduDianna Howard, MD
PRINCIPAL INVESTIGATOR
Wake Forest University Health Sciences
Frequently Asked Questions
Who can join the NCT01890486 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 120 Years, studying Acute Myelogenous Leukemia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01890486 currently recruiting?
Yes, NCT01890486 is actively recruiting participants. Contact the research team at dhoward@wakehealth.edu for enrollment information.
Where is the NCT01890486 trial being conducted?
This trial is being conducted at Winston-Salem, United States.
Who is sponsoring the NCT01890486 clinical trial?
NCT01890486 is sponsored by Wake Forest University Health Sciences. The principal investigator is Dianna Howard, MD at Wake Forest University Health Sciences. The trial plans to enroll 2,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.